Michael J. Berna

Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor

Amy C. Porter, John‐Michael Sauer, Michael D. Knierman et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 609 citations

Quantitative analysis of amyloid <i>β</i> peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry

Tomoyuki Oe, Bradley L. Ackermann, Kōichi Inoue et al. · Rapid Communications in Mass Spectrometry · 2006 · 164 citations

Strategic Use of Immunoprecipitation and LC/MS/MS for Trace-Level Protein Quantification:  Myosin Light Chain 1, a Biomarker of Cardiac Necrosis

Michael J. Berna, Yuejun Zhen, David E. Watson et al. · Analytical Chemistry · 2007 · 106 citations

Cardiac Muscle, Heart Failure, Engineering +20

Quantification of NTproBNP in Rat Serum Using Immunoprecipitation and LC/MS/MS:  a Biomarker of Drug-Induced Cardiac Hypertrophy

Michael J. Berna, Lee W. Ott, Steve Engle et al. · Analytical Chemistry · 2008 · 70 citations

Cardiomyopathy, Heart Failure, Cardiovascular Disease +14

Online immunoaffinity liquid chromatography/tandem mass spectrometry determination of a type II collagen peptide biomarker in rat urine: Investigation of the impact of collision-induced dissociation fluctuation on peptide quantitation

Michael J. Berna, C. Schmalz, Kevin L. Duffin et al. · Analytical Biochemistry · 2006 · 53 citations

Biomarker (Medicine), Collision-induced Dissociation Fluctuation, Biochemistry +14